BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9604553)

  • 1. Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms.
    Piasecki TM; Fiore MC; Baker TB
    J Abnorm Psychol; 1998 May; 107(2):238-51. PubMed ID: 9604553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy.
    Shiffman S; Ferguson SG; Gwaltney CJ; Balabanis MH; Shadel WG
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):637-44. PubMed ID: 16261317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression following smoking cessation in women.
    Bock BC; Goldstein MG; Marcus BH
    J Subst Abuse; 1996; 8(1):137-44. PubMed ID: 8743774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity.
    Piasecki TM; Jorenby DE; Smith SS; Fiore MC; Baker TB
    Exp Clin Psychopharmacol; 2003 Nov; 11(4):276-85. PubMed ID: 14599261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial.
    Ferguson SG; Shiffman S; Gwaltney CJ
    J Consult Clin Psychol; 2006 Dec; 74(6):1153-61. PubMed ID: 17154744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine deprivation attenuates panic reactivity in smokers: Findings from a placebo-controlled nicotine patch study.
    Abrams K; Krimmel S; Johnson S; Cieslowski K; Strnad H; Melum A; Kryder C
    Depress Anxiety; 2017 Nov; 34(11):996-1005. PubMed ID: 28489321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.
    Levin ED; Westman EC; Stein RM; Carnahan E; Sanchez M; Herman S; Behm FM; Rose JE
    J Clin Psychopharmacol; 1994 Feb; 14(1):41-9. PubMed ID: 8151002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute nicotine reinforcement, but not chronic tolerance, predicts withdrawal and relapse after quitting smoking.
    Perkins KA; Broge M; Gerlach D; Sanders M; Grobe JE; Cherry C; Wilson AS
    Health Psychol; 2002 Jul; 21(4):332-9. PubMed ID: 12090675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
    Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB
    Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers.
    Piasecki TM; Jorenby DE; Smith SS; Fiore MC; Baker TB
    J Abnorm Psychol; 2003 Feb; 112(1):3-13. PubMed ID: 12653409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales.
    West R; Ussher M; Evans M; Rashid M
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):619-27. PubMed ID: 16308727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers.
    Tiffany ST; Cox LS; Elash CA
    J Consult Clin Psychol; 2000 Apr; 68(2):233-40. PubMed ID: 10780123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 'nicotine replacement paradox' in smoking cessation: how does nicotine gum really work?
    West R
    Br J Addict; 1992 Feb; 87(2):165-7. PubMed ID: 1554992
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle.
    Allen SS; Hatsukami D; Christianson D; Brown S
    Nicotine Tob Res; 2000 Aug; 2(3):231-41. PubMed ID: 11082823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.